About Clinical Cancer Advances
ASCO develops this annual report, now in its 13th edition, to outline the progress that has been achieved in clinical cancer research and care each year. As a whole, Clinical Cancer Advances highlights current trends in the field and previews future directions of cancer research.
The content of this report was developed under the direction of a 20-person editorial board composed of experts in a wide range of cancer types, as well as surgical oncology, radiation oncology, cancer prevention and screening, quality of care, health disparities, tumor biology, and developmental therapeutics. The editors reviewed scientific literature that was published in peer-reviewed journals or presented at major medical conferences from October 2016 through September 2017 and selected advances according to formal criteria. Primarily, advances must improve meaningful patient outcomes, such as survival or quality of life, and have a strong scientific impact.